Pursuant to Regulation 30 of the SEBI (LODR)Regulations, 2015 the Analysts/Investors meet is Scheduled on Friday, 22nd May 2026 at 11:00 a.m. to discuss the operational & financial performance ....
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudeep Pharma Limited has scheduled an earnings call for Friday, 22nd May 2026 at 11:00 AM to discuss Q4 and FY26 operational and financial performance. The call will feature MD Mr. Sujit Bhayani, Director Mr. Shanil Bhayani, and CFO Mr. Ketan Vyas. The company has invited analysts and investors to pre-register for the call, with access numbers provided for international participation. This filing complies with Regulation 30 of SEBI Listing Regulations, 2015.
This announcement signals upcoming Q4/FY26 earnings disclosure and provides an opportunity for investor engagement. The scheduled earnings call indicates the company is preparing to release its quarterly and annual results, which could lead to increased volatility or movement in the stock.